NEW YORK (GenomeWeb) – Vanderbilt University Medical Center today announced a collaboration with BioReference Laboratories for tumor profiling in cancer care.

Under the terms of the multiyear agreement, the partners will develop a next-generation sequencing panel for tumors and hematologic malignancies, aiming to make it available in 2016 for use in clinical oncology. The panel is expected to comprise more than 300 genes and will target SNPs, insertions and deletions, CNVs, and gene fusions in regions of the genome that are druggable.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.